Senior Director of National Accounts - National Payers and SPs
No salary listed
Expert
Bachelor's, MBA
Remote in USA
RemoteRemote within the United States, with travel up to 50%.
Sales & Account ManagementAccount Management
About the job
Requirements
- A B.A. or B.S. degree is required.
- 12–15 years of experience in the biotech industry, preferably involving rare and orphan disease medicines.
- At least 5 years of payer experience, including channel account management.
- Experience in pharmaceutical product marketing and/or sales.
- Prior success leading, managing, and developing teams, including remote personnel.
- Demonstrated success achieving formulary coverage for branded specialty products.
- Demonstrated account-management success across specialty pharmacies, group purchasing organizations, integrated health systems, and payers.
- Knowledge of relevant legal, compliance, and regulatory requirements.
- Proven ability to provide strategic input into access strategies and implement tactical action plans, including pricing and contracting strategies aligned with brand business objectives.
- Strong leadership, planning, decision-making, and problem-solving skills focused on delivering results.
- A proven record of working with cross-functional teams and educating and influencing multiple organizational levels.
- Strong attention to detail and ability to recognize issues in the context of higher-level policies and regulations.
- Strong interpersonal and peer-leadership skills, including the ability to influence without authority and work cross-functionally in a highly dynamic environment.
- Excellent written and verbal communication skills.
- Proficiency in Microsoft Office.
- Ability to travel up to 50%.
Responsibilities
- Provide customer-segment perspective for the development of market-access strategies for key brands.
- Provide input into brand-value-platform development and ensure account managers are informed and trained to deliver the value proposition and core messaging to accounts.
- Maintain understanding of brand business objectives with a focus on channel optimization.
- Build and maintain relationships with commercial and public-sector payers and aligned specialty pharmacies.
- Drive profitable access for brands across relevant payers within approved guidelines.
- Monitor the external environment, customers, and competitors to identify opportunities for brand differentiation and access enhancement.
- Own account-deployment decisions, account strategies, account-level business-plan development, and national-account direction to drive the business.
- Participate in the Contract Review Committee and Pricing Committee and collaborate on recommendations with Market Access, Finance, Legal, and Marketing.
- Work with internal and external business partners to achieve account-specific objectives.
- Develop and maintain industry contacts to obtain environmental, competitive, and product-specific insight.
- Build and maintain customer relationships to create a foundation for new business opportunities.
- Provide strategic leadership to the Market Access Accounts team, develop talent, and translate organizational priorities into effective account strategies.
- Drive organizational effectiveness and results through coaching, performance management, capability development, and a culture of accountability, collaboration, compliance, and continuous improvement.
- Work with the Executive Director of Market Access Accounts to foster innovation and creativity while leading and performing with integrity.
Desired Qualifications
- An MBA or other advanced degree is preferred.
- Experience in rare and orphan disease medicines is preferred.
About the company
CSL is a global biotechnology company that develops and delivers biotherapies and influenza vaccines. It focuses on plasma-derived and recombinant therapies for rare and serious diseases and sells to healthcare providers, hospitals, and governments across the Americas, Asia Pacific, and Europe. Its product range includes treatments for rare diseases, influenza vaccines, and antivenoms, produced through its R&D, manufacturing, and distribution operations. CSL differentiates itself by offering the broadest portfolio of plasma-derived and recombinant therapies and by leveraging its global footprint and emphasis on diversity to reach diverse markets. The company’s main goal is to save lives and protect health by expanding access to high-quality therapies and vaccines worldwide.
Company Size
10,001+
Company Stage
IPO
Headquarters
Parkville, Australia
Founded
1916
Get referred to CSL
See people who can refer or advise you
Simplify's Take
What believers are saying
- CSL reported US$176 million FY26 cost savings, ahead of its transformation target.
- US military flu-vaccine exceptions restored some demand after April 2026 mandate cuts.
- VarmX’s 2029 coagulation program gives CSL a new high-value pipeline beyond plasma.
What critics are saying
- FY26 statutory loss hit US$2.6 billion after US$7.1 billion impairments and restructuring.
- CSL plans US$400 million FY27 savings, implying more closures, layoffs, and execution friction.
- The U.S. plasma turnaround depends on Horizon 2; failure risks long-term margin collapse.
What makes CSL unique
- CSL’s FY26 revenue reached US$15.8 billion across plasma, vaccines, and Vifor.
- Seqirus’ AUJEMFLU won UK and European approvals, backed by Lancet Phase 3 data.
- HEMGENIX remains Europe’s first approved hemophilia B gene therapy, strengthening CSL Behring.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- 401(k) Retirement Plan
- 401(k) Company Match
- Paid Time Off
- Paid Vacation
- Paid Sick Leave
- Paid Holidays